Skip to Content

Vaccines, Volume 3, Issue 3

2015 September - 15 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (15)

  • Review
  • Open Access
10 Citations
8,972 Views
32 Pages

17 September 2015

Transcription is a dynamic process influenced by the cellular environment: healthy, transformed, and otherwise. Genome-wide mRNA expression profiles reflect the collective impact of pathways modulating cell function under different conditions. In thi...

  • Article
  • Open Access
46 Citations
7,679 Views
20 Pages

New Data on Vaccine Antigen Deficient Bordetella pertussis Isolates

  • Valérie Bouchez,
  • Nicolas Hegerle,
  • Francesco Strati,
  • Elisabeth Njamkepo and
  • Nicole Guiso

14 September 2015

Evolution of Bordetella pertussis is driven by natural and vaccine pressures. Isolates circulating in regions with high vaccination coverage present multiple allelic and antigenic variations as compared to isolates collected before introduction of va...

  • Article
  • Open Access
27 Citations
9,787 Views
21 Pages

Chitosan-Poly (I:C)-PADRE Based Nanoparticles as Delivery Vehicles for Synthetic Peptide Vaccines

  • Jorge F. Correia-Pinto,
  • Noemi Csaba,
  • John T. Schiller and
  • Maria J. Alonso

11 September 2015

The safety and precision of peptide antigens has prompted the search for adjuvants capable of increasing the immune response against these intrinsically poorly immunogenic antigens. The integration of both immunostimulants and peptide antigens within...

  • Review
  • Open Access
307 Citations
20,062 Views
27 Pages

The Role of Indoleamine 2, 3-Dioxygenase in Immune Suppression and Autoimmunity

  • Jacques C. Mbongue,
  • Dequina A. Nicholas,
  • Timothy W. Torrez,
  • Nan-Sun Kim,
  • Anthony F. Firek and
  • William H.R. Langridge

10 September 2015

Indoleamine 2, 3-dioxygenase (IDO) is the first and rate limiting catabolic enzyme in the degradation pathway of the essential amino acid tryptophan. By cleaving the aromatic indole ring of tryptophan, IDO initiates the production of a variety of try...

  • Review
  • Open Access
43 Citations
9,084 Views
17 Pages

Gas Vesicle Nanoparticles for Antigen Display

  • Shiladitya DasSarma and
  • Priya DasSarma

7 September 2015

Microorganisms like the halophilic archaeon Halobacterium sp. NRC-1 produce gas-filled buoyant organelles, which are easily purified as protein nanoparticles (called gas vesicles or GVNPs). GVNPs are non-toxic, exceptionally stable, bioengineerable,...

  • Review
  • Open Access
249 Citations
23,551 Views
24 Pages

27 August 2015

Recent studies have demonstrated great therapeutic potential of educating and unleashing our own immune system for cancer treatment. However, there are still major challenges in cancer immunotherapy, including poor immunogenicity of cancer vaccines,...

  • Article
  • Open Access
31 Citations
8,468 Views
24 Pages

10 August 2015

Despite the discovery of many potential antigens for subunit vaccines, universal protection is often lacking due to the limitations of conventional delivery methods. Subunit vaccines primarily induce antibody-mediated humoral responses, whereas pote...

  • Review
  • Open Access
67 Citations
9,683 Views
18 Pages

Plant Viruses as Nanoparticle-Based Vaccines and Adjuvants

  • Marie-Ève Lebel,
  • Karine Chartrand,
  • Denis Leclerc and
  • Alain Lamarre

5 August 2015

Vaccines are considered one of the greatest medical achievements in the battle against infectious diseases. However, the intractability of various diseases such as hepatitis C, HIV/AIDS, malaria, tuberculosis, and cancer poses persistent hurdles give...

  • Review
  • Open Access
53 Citations
9,983 Views
23 Pages

30 July 2015

The significant contribution of host immunity in early tumorigenesis has been recently recognized as a result of our better understanding of the molecular pathways regulating tumor cell biology and tumor-lymphocyte interactions. Emerging evidence sug...

  • Review
  • Open Access
173 Citations
13,366 Views
18 Pages

24 July 2015

Cholera toxin subunit B (CTB) is the nontoxic portion of cholera toxin. Its affinity to the monosialotetrahexosylganglioside (GM1) that is broadly distributed in a variety of cell types including epithelial cells of the gut and antigen presenting cel...

  • Article
  • Open Access
19 Citations
8,819 Views
23 Pages

Addressing the Vaccine Hesitancy Continuum: An Audience Segmentation Analysis of American Adults Who Did Not Receive the 2009 H1N1 Vaccine

  • Shoba Ramanadhan,
  • Ezequiel Galarce,
  • Ziming Xuan,
  • Jaclyn Alexander-Molloy and
  • Kasisomayajula Viswanath

15 July 2015

Understanding the heterogeneity of groups along the vaccine hesitancy continuum presents an opportunity to tailor and increase the impact of public engagement efforts with these groups. Audience segmentation can support these goals, as demonstrated h...

  • Review
  • Open Access
13 Citations
7,988 Views
12 Pages

Systems Biology Approach for Cancer Vaccine Development and Evaluation

  • Luisa Circelli,
  • Annacarmen Petrizzo,
  • Maria Tagliamonte,
  • Maria Lina Tornesello,
  • Franco M. Buonaguro and
  • Luigi Buonaguro

14 July 2015

Therapeutic cancer vaccines do not hold promise yet as an effective anti-cancer treatment. Lack of efficacy or poor clinical outcomes are due to several antigenic and immunological aspects that need to be addressed in order to reverse such trends and...

  • Article
  • Open Access
20 Citations
8,562 Views
25 Pages

Anti-Tumor Effects of Peptide Therapeutic and Peptide Vaccine Antibody Co-targeting HER-1 and HER-2 in Esophageal Cancer (EC) and HER-1 and IGF-1R in Triple-Negative Breast Cancer (TNBC)

  • Jay Overholser,
  • Kristen Henkins Ambegaokar,
  • Siobhan M. Eze,
  • Eduardo Sanabria-Figueroa,
  • Rita Nahta,
  • Tanios Bekaii-Saab and
  • Pravin T.P. Kaumaya

6 July 2015

Despite the promise of targeted therapies, there remains an urgent need for effective treatment for esophageal cancer (EC) and triple-negative breast cancer (TNBC). Current FDA-approved drugs have significant problems of toxicity, safety, selectivity...

  • Article
  • Open Access
20 Citations
7,812 Views
16 Pages

Immunogenic Subviral Particles Displaying Domain III of Dengue 2 Envelope Protein Vectored by Measles Virus

  • Indira S. Harahap-Carrillo,
  • Ivonne Ceballos-Olvera and
  • Jorge Reyes-del Valle

3 July 2015

Vaccines against dengue virus (DV) are commercially nonexistent. A subunit vaccination strategy may be of value, especially if a safe viral vector acts as biologically active adjuvant. In this paper, we focus on an immunoglobulin-like, independently...

  • Review
  • Open Access
44 Citations
7,340 Views
13 Pages

Interest of Tumor-Specific CD4 T Helper 1 Cells for Therapeutic Anticancer Vaccine

  • Jeanne Galaine,
  • Christophe Borg,
  • Yann Godet and
  • Olivier Adotévi

30 June 2015

Nowadays, immunotherapy represents one promising approach for cancer treatment. Recently, spectacular results of cancer immunotherapy clinical trials have confirmed the crucial role of immune system in cancer regression. Therapeutic cancer vaccine re...

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Vaccines - ISSN 2076-393X